AS Watson, the Hong Kong-based owner of Superdrug, is shrugging off market volatility and geopolitical turmoil to push ahead with plans for a $30bn dual stock market listing in the second half of this year.
总部位于香港的Superdrug母公司屈臣氏集团(AS Watson)，不顾市场波动和地缘政治动荡，仍将推进价值300亿美元的双重上市计划，拟于今年下半年在两地证券市场挂牌。
您已阅读4%（293字），剩余96%（6226字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。